Screener
Krystal Biotech, Inc. KRYS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchases of property and equipment | (7,148) | (6,204) |
| Purchases of investments | (160,033) | (137,806) |
| Maturities of investments | 103,598 | 88,806 |
| Net cash (used in) investing activities | (63,583) | (54,769) |
| Financing Activities | ||
| Proceeds from exercise of stock options | 6,501 | 1,462 |
| Taxes paid for employee tax withholding related to restricted stock units | (16,960) | (12,116) |
| Taxes paid related to settlement of restricted stock awards | — | (1,812) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s investing cash flow?
- Krystal Biotech, Inc. (KRYS) reported investing cash flow of -$63.58M in Q1 2026.
- How has Krystal Biotech, Inc.'s investing cash flow changed year-over-year?
- Krystal Biotech, Inc.'s investing cash flow decreased by 16.1% year-over-year, from -$54.77M to -$63.58M.
- What is the long-term trend for Krystal Biotech, Inc.'s investing cash flow?
- Over 2 years (2021 to 2024), Krystal Biotech, Inc.'s investing cash flow has grown at a -15.1% compound annual growth rate (CAGR), from -$226.77M to -$163.44M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Krystal Biotech, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude